1. Heiss WD. Flow thresholds of functional and morphological damage of brain tissue. Stroke 1983; 14: 329–31.
2. Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363 (9411): 768–74.
3. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581–7.
4. Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4,5 hours after acute ischemic stroke. N Engl J Med 2008; 359 (13): 1317–29.
5. Wahlgren N, Ahmed N, Da?valos A et al. Thrombolysis with alteplase 3–4,5 h after acute ischaemic stroke (SITSISTR): an observational study. Lancet 2008; 372 (9646): 1303–9.
6. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25 (5): 457–507.
7. Bladin C, Fink J, Tress B et al. Transformation Postthrombolysis Blood Pressure Elevation Is Associated With Hemorrhagic. Stroke 2010; 41: 72–7.
8. Delgado O, Maisterra J, Alvarez-Sabin et al. Prognostic significance of blood pressure variability after thrombolysis in acute Neurology 2008; 71: 552–8.
9. Myzoon A, Philip M, Curram J et al. The Virtual International Stroke Trials Archive. Stroke 2007; 38: 1905–10.
10. The International Stroke Thrombolysis Register for Safe Implementation of Thrombolysis in Stroke (SITS). 2001 European Stroke Conference.
11. Alexandrov AV, Demchuk AM, Burgin WS et al. Ultrasound-Enhanced Thrombolysis for Acute Ischemic Stroke: Phase I. Findings of the CLOTBUST Trial. J Neuroimaging 2004; 14: 113–7.12.
Lisboa C et al. Analysis of the Safety and Efficacy of Intra-Arterial Thrombolytic Therapy in Ischemic Stroke. Stroke 2002; 33: 2866.
13. Furlan A, Higashida R, Wechsler L et al. The PROACT II Study: A Randomized Controlled Trial Intra-arterial Prourokinase for Acute Ischemic Stroke: Pro-Urokinase in Acute Cerebral Thromboembolism. JAMA 1999; 282 (21): 2003–11.
14. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003; 34: 2729–35.
15. Nishant K, Mishra M, Gregory W et al. Mismatch – Based Delayed Thrombolysis. A Meta-Analysis. Stroke 2010; 41 (1): 25–33.
16. Olivor JM, Mlynash M, Zaharchuk G et al. Perfusion MRI (Tmax and MTT) correlation with xenon CT cerebral blood flow in stroke patients. Neurology 2009; 72: 1140–5.
17. De Sieva DA, Fink JN et al. Assessing Reperfusion and Recanalization as Markers of Clinical Outcomes After Intravenous Thrombolysis in Echoplanar Imaging Thrombolytic Evaluation Tial (EPITHET). Stroke 2009; 40: 2872–4.
18. Хасанова Д.Р., Демин Т.В., Володюхин М.Ю, Сайхунов М.В. Особенности применения реперфузионных технологий в период «терапевтического окна» ишемического инсульта. Невролог. журн. 2009; 5: 28–31.
19. Хасанова Д.Р., Сайхунов М.В., Демин Т.В. и др. Опыт реканализационной терапии у больных с ИИ в условиях Межрегионального клинико-диагностического центра, г. Казань. Журн. неврол. и психиат. им. С.С.Корсакова. 2008; 22: 22–9.
20. Khatri P, Abrusso T, Yatts SD et al. Good clinical outcome after ischemic stroke with success revascularization is time-depend. Neurology 2010; 1066–72.
21. Mattle HP, Arnold M, Georgiadis D et al. Comparison of Intraarterial and Intravenous Thrombolysis for Ischemic Stroke With Hyperdense Middle Cerebral Artery Sign Stroke 2007; doi: 10.1161/STROKEAHA.107.492348.
22. Kharitonova T, Ahmed N, Thore?n M et al. Hyperdense middle cerebral artery sign on admission CT scan – prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the Safe Implementation of Thrombolysis in Stroke International Stroke Thrombolysis Register. Cerebrovasc Dis 2009; 27: 51–9.
23. Kharitonova T, Thoren M, Ahmed N et al. Disappearing hyperdens middle cerebral artery sing in ischemic stroke patients treated with intravenous thrombolysis. J Neurol Neurosurg Psychiatry 2009; 80: 273–8.
24. Sekoranja L, Loulidi J, Yulmaz H. Intravenouse versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke. Stroke 2006; 37: 1805–9.
25. Ogawa A, Mori E, Minematsu K et al. Randomized trial of intra-arterial infusionof urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007; 38: 2633–9.
26. Lewandowski CA, Frankel M, Tomsick TA. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of ischemic stroke: Emergency Management of
stroke (EMS) Bridging Trial. Stroke.
27. Mauldin PD, Simpson KN, Palesch YY et al. For the IMS III Investigators. Int J Stroke 2008; 3: 138–44. [View the article] Methodology of the Interventional Management of Stroke III Trial.
28. Ciccone A, Valvassori L, Ponzio M et al. The SYNTHESIS Investigators.Ischemic stroke. Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS
pilot trial NeuroIntervent Surg 2010; 2: 74–9, doi:10.1136/jnis.2009.001388.
29. Moonis Intraarterial Thrombolysis Within the First Three Hours After Acute Ischemic Stroke in Selected Patients Stroke. 2009; 40 (7): 2611–2.